Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease

Summary

This is a phase 2, multi-center, double-masked, randomized, vehicle-controlled, dose-response, parallel-group study designed to evaluate the safety and tolerability and ocular efficacy of SY-201 Ophthalmic Solution versus vehicle over a 60-day treatment period in subjects with dry eye disease (DED).

Timeline

Start

2022-07-25

Primary completion

2023-03-24

Completion

2023-03-24

Drugs

Indications